ASCO® 2025 Highlights: Presenter Vignette – Martin Reck

Dr. Martin Reck

Martin Reck

MD, PhD

LungenClinic Grosshansdorf

8009

Association of post-surgical MRD status with neoadjuvant ctDNA dynamics, genomic mutations, and clinical outcomes in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial.

Interested in learning more about these abstracts and other trials presented at ASCO® 2025? Be sure to register for one of our licensed Best of ASCO® events in a city near you.

This program has been made possible through unrestricted support from Boehringer Ingelheim, Eli Lilly and Ipsen